Hefei Lifeon Pharmaceutical Co Ltd banner

Hefei Lifeon Pharmaceutical Co Ltd
SZSE:003020

Watchlist Manager
Hefei Lifeon Pharmaceutical Co Ltd Logo
Hefei Lifeon Pharmaceutical Co Ltd
SZSE:003020
Watchlist
Price: 24.68 CNY 1.86% Market Closed
Market Cap: ¥4.7B

Relative Value

The Relative Value of one Hefei Lifeon Pharmaceutical Co Ltd stock under the Base Case scenario is hidden CNY. Compared to the current market price of 24.68 CNY, Hefei Lifeon Pharmaceutical Co Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Hefei Lifeon Pharmaceutical Co Ltd Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Multiples Across Competitors

Competitors Multiples
Hefei Lifeon Pharmaceutical Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Hefei Lifeon Pharmaceutical Co Ltd
SZSE:003020
4.7B CNY 3.2 29 28.4 28.4
US
Eli Lilly and Co
NYSE:LLY
934.4B USD 14.5 45.8 30.9 33
US
Johnson & Johnson
NYSE:JNJ
578.8B USD 6.2 21.8 15.1 18.6
CH
Roche Holding AG
SIX:ROG
262.7B CHF 4.3 20.4 12 13.6
CH
Novartis AG
SIX:NOVN
238.2B CHF 5.5 22.1 13.7 17.5
UK
AstraZeneca PLC
LSE:AZN
221.2B GBP 5.1 29.3 16.2 22.9
US
Merck & Co Inc
NYSE:MRK
284.1B USD 4.4 15.8 9.8 11.9
IE
Endo International PLC
LSE:0Y5F
218B USD 94 -74.6 344.9 865
DK
Novo Nordisk A/S
CSE:NOVO B
1.1T DKK 3.6 10.9 8.1 9.5
US
Pfizer Inc
NYSE:PFE
150.2B USD 2.4 19.5 7.5 10
US
Bristol-Myers Squibb Co
NYSE:BMY
119.4B USD 2.5 17.2 7.2 8.9
P/E Multiple
Earnings Growth PEG
CN
Hefei Lifeon Pharmaceutical Co Ltd
SZSE:003020
Average P/E: 23.2
29
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
45.8
32%
1.4
US
Johnson & Johnson
NYSE:JNJ
21.8
7%
3.1
CH
Roche Holding AG
SIX:ROG
20.4
14%
1.5
CH
Novartis AG
SIX:NOVN
22.1
14%
1.6
UK
AstraZeneca PLC
LSE:AZN
29.3
26%
1.1
US
Merck & Co Inc
NYSE:MRK
15.8
14%
1.1
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -74.6 N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
10.9
1%
10.9
US
Pfizer Inc
NYSE:PFE
19.5
22%
0.9
US
Bristol-Myers Squibb Co
NYSE:BMY
17.2
16%
1.1
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CN
Hefei Lifeon Pharmaceutical Co Ltd
SZSE:003020
Average EV/EBITDA: 44.9
28.4
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
30.9
22%
1.4
US
Johnson & Johnson
NYSE:JNJ
15.1
2%
7.6
CH
Roche Holding AG
SIX:ROG
12
6%
2
CH
Novartis AG
SIX:NOVN
13.7
5%
2.7
UK
AstraZeneca PLC
LSE:AZN
16.2
13%
1.2
US
Merck & Co Inc
NYSE:MRK
9.8
3%
3.3
IE
E
Endo International PLC
LSE:0Y5F
344.9
N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
8.1
1%
8.1
US
Pfizer Inc
NYSE:PFE
7.5
-9%
N/A
US
Bristol-Myers Squibb Co
NYSE:BMY
7.2
-10%
N/A
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett